Biosimilars and PBMs: The Joke’s on Us
April 12, 2023 — Two innovations in health systems and health policy – PBMs and biosimilars – are supposed to save us money on drugs. But so far, it looks like the joke is on us. PBMs (pharmacy benefit managers) can actually drive prices higher. Their stated purpose is just the opposite – to drive drug costs down. Adding […]
